Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (111-120 of 425) with videos related to

Pageof 43
Sort By:
Vascular Health and Risk Management|December 12, 2019
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated PatientsPeter P Toth, Sephy Philip, Michael Hull, et al.
Current Opinion in Cardiology|May 25, 2016
IMPROVE-IT: what have we learned?Maciej Banach, Dragana Nikolic, Manfredi Rizzo, et al.
Mayo Clinic Proceedings|August 14, 2019
Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated PatientsPeter P Toth, Sephy Philip, Michael Hull, et al.
Trends in Endocrinology and Metabolism: TEM|June 17, 2014
High-density lipoprotein subfractions: current views and clinical practice applicationsSeth S Martin, Steven R Jones, Peter P Toth
Clinical Cardiology|August 2, 2019
Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysisPeter P Toth, Sephy Philip, Michael Hull, et al.
International Journal of Cardiology|October 12, 2016
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvementMaciej Banach, Tomas Stulc, Ricardo Dent, et al.
Current Atherosclerosis Reports|December 17, 2008
Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acidsPeter P Toth, Thomas D Dayspring, Gregory S Pokrywka
Archives of Medical Science : AMS|May 20, 2022
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterolIstvan Reiber, Laszlo Mark, Gyorgy Paragh, et al.
American Journal of Preventive Cardiology|September 20, 2022
There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectivenessMichael E Makover, Michael D Shapiro, Peter P Toth
American Journal of Preventive Cardiology|September 15, 2020
Targeting hypertriglyceridemia to mitigate cardiovascular risk: A reviewPeter P Toth, Prediman K Shah, Norman E Lepor
Pageof 43

Showing results (111-120 of 425) with videos related to

Sort By:
Pageof 43
Vascular Health and Risk Management|December 12, 2019
Elevated Triglycerides (≥150 mg/dL) and High Triglycerides (200-499 mg/dL) Are Significant Predictors of New Heart Failure Diagnosis: A Real-World Analysis of High-Risk Statin-Treated PatientsPeter P Toth, Sephy Philip, Michael Hull, et al.
Current Opinion in Cardiology|May 25, 2016
IMPROVE-IT: what have we learned?Maciej Banach, Dragana Nikolic, Manfredi Rizzo, et al.
Mayo Clinic Proceedings|August 14, 2019
Association of Elevated Triglycerides With Increased Cardiovascular Risk and Direct Costs in Statin-Treated PatientsPeter P Toth, Sephy Philip, Michael Hull, et al.
Trends in Endocrinology and Metabolism: TEM|June 17, 2014
High-density lipoprotein subfractions: current views and clinical practice applicationsSeth S Martin, Steven R Jones, Peter P Toth
Clinical Cardiology|August 2, 2019
Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysisPeter P Toth, Sephy Philip, Michael Hull, et al.
International Journal of Cardiology|October 12, 2016
Statin non-adherence and residual cardiovascular risk: There is need for substantial improvementMaciej Banach, Tomas Stulc, Ricardo Dent, et al.
Current Atherosclerosis Reports|December 17, 2008
Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acidsPeter P Toth, Thomas D Dayspring, Gregory S Pokrywka
Archives of Medical Science : AMS|May 20, 2022
Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin/Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterolIstvan Reiber, Laszlo Mark, Gyorgy Paragh, et al.
American Journal of Preventive Cardiology|September 20, 2022
There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: A review of current practice and recommendations for improved effectivenessMichael E Makover, Michael D Shapiro, Peter P Toth
American Journal of Preventive Cardiology|September 15, 2020
Targeting hypertriglyceridemia to mitigate cardiovascular risk: A reviewPeter P Toth, Prediman K Shah, Norman E Lepor
Pageof 43